Marcello Arca

Pubblicazioni

Titolo Pubblicato in Anno
Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries CARDIOVASCULAR THERAPEUTICS 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2020
Association of hypertriglyceridemia with all-cause mortality and atherosclerotic cardiovascular events in a low-risk italian population: The TG-REAL Retrospective Cohort Analysis JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2020
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts GIORNALE ITALIANO DI CARDIOLOGIA 2020
Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies JOURNAL OF CARDIOVASCULAR MEDICINE 2020
Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials CURRENT ATHEROSCLEROSIS REPORTS 2020
Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia EXPERT OPINION ON PHARMACOTHERAPY 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry INTERNATIONAL JOURNAL OF CARDIOLOGY 2020
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features ATHEROSCLEROSIS 2020
ApoCIII: A multifaceted protein in cardiometabolic disease METABOLISM, CLINICAL AND EXPERIMENTAL 2020
Familial combined hypolipidemia: Angiopoietin-like protein-3 deficiency CURRENT OPINION IN LIPIDOLOGY 2020
Autosomal recessive hypercholesterolemia: update for 2020 CURRENT OPINION IN LIPIDOLOGY 2020
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia ATHEROSCLEROSIS SUPPLEMENTS 2020
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects DIABETES/METABOLISM RESEARCH AND REVIEWS 2020
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2019
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity PEDIATRIC RESEARCH 2019
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease LIVER INTERNATIONAL 2019
Variation of PEAR1 DNA methylation influences platelet and leukocyte function. CLINICAL EPIGENETICS 2019
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma